Side Effects of External Beam Radiation Therapy...

It is important to understand the potential side effects that may result from external beam radiation therapy (EBRT) for prostate cancer.
Source: About.com Prostate Cancer - Category: Cancer & Oncology Tags: health Source Type: news

Related Links:

In conclusion, a risk of urinary infections in cancer patients treated with pelvic radiotherapy was observed, in order to reduce the use of antibiotic resistance, preventive treatment with non-antibiotic agents 5 are warranted.
Source: Reports of Practical Oncology and Radiotherapy - Category: Cancer & Oncology Source Type: research
Publication date: July 2018Source: European Urology, Volume 74, Issue 1Author(s): Mark Douglas Tyson, Tatsuki Koyama, Dan Lee, Karen E. Hoffman, Matthew J. Resnick, Xiao-Cheng Wu, Matthew R. Cooperberg, Michael Goodman, Sheldon Greenfield, Ann S. Hamilton, Mia Hashibe, Lisa E. Paddock, Antoinette Stroup, Vivien Chen, Ralph Conwill, Dan McCollum, David F. Penson, Daniel A. BarocasAbstractBackgroundWhether prostate cancer severity modifies patient-reported functional outcomes after radical prostatectomy (RP) or external beam radiotherapy (EBRT) for localized cancer is unknown.ObjectiveThe purpose of this study was to determi...
Source: European Urology - Category: Urology & Nephrology Source Type: research
Publication date: May–June 2018Source: Practical Radiation Oncology, Volume 8, Issue 3Author(s): Hann-Hsiang Chao, Abigail Doucette, David M. Raizen, Neha VapiwalaAbstractPurposeFatigue is a common adverse effect among cancer patients undergoing external beam radiation therapy (EBRT), yet the underlying disease- and treatment-related factors influencing its development are poorly understood. We hypothesized that clinical, demographic, and treatment-related factors differentially affect fatigue and aimed to better characterize variables related to fatigue development in prostate cancer (PC) patients during EBRT.Method...
Source: Practical Radiation Oncology - Category: Cancer & Oncology Source Type: research
Publication date: Available online 14 April 2018Source: Practical Radiation OncologyAuthor(s): Stephen A. Mihalcik, Jonathan J. Chipman, Martin G. Sanda, Meredith M. Regan, Irving D. Kaplan, Andrew A. Wagner, Catrina M. Crociani, Peter Chang, PROST-QA Consortium
Source: Practical Radiation Oncology - Category: Cancer & Oncology Source Type: research
Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU Abstract PURPOSE: Gleason score (GS) 10 disease is the most aggressive form of clinically localized prostate adenocarcinoma (PCa). The long-term clinical outcomes and overall prognosis of patients presenting with GS 10 PCa are largely unknown because of its rarity. METHODS AND MATERIALS: The study included 112 patients with biopsy-determined GS 10 PCa who received treatment with radical prostatectomy (RP, n = 26), external bea...
Source: Ann Oncol - Category: Cancer & Oncology Authors: Tags: Int J Radiat Oncol Biol Phys Source Type: research
Publication date: July 2018Source: European Urology, Volume 74, Issue 1Author(s): Mark Douglas Tyson, Tatsuki Koyama, Dan Lee, Karen E. Hoffman, Matthew J. Resnick, Xiao-Cheng Wu, Matthew R. Cooperberg, Michael Goodman, Sheldon Greenfield, Ann S. Hamilton, Mia Hashibe, Lisa E. Paddock, Antoinette Stroup, Vivien Chen, Ralph Conwill, Dan McCollum, David F. Penson, Daniel A. BarocasAbstractBackgroundWhether prostate cancer severity modifies patient-reported functional outcomes after radical prostatectomy (RP) or external beam radiotherapy (EBRT) for localized cancer is unknown.ObjectiveThe purpose of this study was to determi...
Source: European Urology - Category: Urology & Nephrology Source Type: research
Publication date: May–June 2018Source: Practical Radiation Oncology, Volume 8, Issue 3Author(s): Hann-Hsiang Chao, Abigail Doucette, David M. Raizen, Neha VapiwalaAbstractPurposeFatigue is a common adverse effect among cancer patients undergoing external beam radiation therapy (EBRT), yet the underlying disease- and treatment-related factors influencing its development are poorly understood. We hypothesized that clinical, demographic, and treatment-related factors differentially affect fatigue and aimed to better characterize variables related to fatigue development in prostate cancer (PC) patients during EBRT.Method...
Source: Practical Radiation Oncology - Category: Cancer & Oncology Source Type: research
Publication date: Available online 14 April 2018Source: Practical Radiation OncologyAuthor(s): Stephen A. Mihalcik, Jonathan J. Chipman, Martin G. Sanda, Meredith M. Regan, Irving D. Kaplan, Andrew A. Wagner, Catrina M. Crociani, Peter Chang, PROST-QA Consortium
Source: Practical Radiation Oncology - Category: Cancer & Oncology Source Type: research
External beam radiation therapy plus a brachytherapy boost (BB) has been shown to offer a 20% improvement in biochemical-free survival compared to dose-escalated external beam radiation therapy for men with intermediate and high-risk prostate cancer, based on the recently published ASCENDE-RT trial. Nevertheless, a National Cancer Database analysis demonstrated a concerning decline in utilization of BB in this population between 2004 and 2013, despite an association with improved overall survival.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research
Publication date: Available online 14 April 2018 Source:Practical Radiation Oncology Author(s): Stephen A. Mihalcik, Jonathan J. Chipman, Martin G. Sanda, Meredith M. Regan, Irving D. Kaplan, Andrew A. Wagner, Catrina M. Crociani, Peter Chang
Source: Practical Radiation Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | External Beam Therapy | Health | Prostate Cancer | Radiation Therapy